Artivion | CRY - Nettoeinkommen

Aktienkurs
37.41
Täglich Wechseln
0.67 1.82%
Monatlich
2.02%
Jährlich
66.05%
Q2 Prognose
36.60




Nettoeinkommen Veränderung Datum
Abbott USD 1.08B 699M 2026-03
Accuray USD 2.54M 6.49M 2024-12
AngioDynamics USD -6.35M 4.55M 2025-09
Artivion USD 2.42M 4.07M 2025-12
AtriCure USD 1.76M 2.02M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Inogen USD -5.96M 373K 2024-09
Integra LifeSciences USD -1.7M 3.7M 2025-12
J&J USD 5.24B 119M 2026-03
Mesa Laboratories USD -1.68M 5.1M 2024-12
Orthofix International USD -2.22M 20.57M 2025-12
Pfizer USD -1.65B 5.19B 2025-12
ResMed USD 392.59M 44.06M 2025-12
Stryker USD 849M 10M 2025-12
Surmodics USD -5.32M 6.22M 2025-06
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Terumo JPY 32.65B 2.4B 2025-12
Trinity Biotech USD -5.14M 11.82M 2025-09